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Abstract
Background: Src kinase plays a critical role in bone
metabolism, particularly in osteoclasts. However, the
ability of Src kinase to modulate the activity of other
bone cells is less well understood. In this work, we
examined the expression and activity of Src and low
molecular weight protein tyrosine phosphatase
(LMWPTP) during osteoblast differentiation and
assessed the modulation of Src kinase by LMWPTP.
Methods: Differentiation of MC3T3-E1 pre-
osteoblasts was induced by incubation with ascorbic
acid and β-glycerophosphate for up to 28 days. Src
phosphorylation and LMWPTP expression were
analyzed by immunoblotting. Src dephosphorylation
in vitro was assessed by incubating immunopre-
cipitated Src with LMWPTP followed by assay of the
residual Src activity using Sam68 as substrate. The
importance of LMWPTP in Src dephosphorylation was
confirmed by silencing pre-osteoblasts with siRNA-
LMWPTP and then assessing Src phosphorylation.
Results: Pre-osteoblast differentiation was accompa-
nied by a decrease in phosphorylation of the activator
site of Src and an increase in phosphorylation of the
inhibitory site. The expression of total Src was
unaltered, indicating that post-translational
modifications play a pivotal role in Src function.
LMWPTP expression was higher in periods when the
activator site of Src was dephosphorylated. LMWPTP
dephosphorylated pY527-Src and pY416-Src in vitro, with
greater specificity for pY527Src. Activation of LMWPTP
produced strong activation of Src mediated by fast
dephosphorylation of pY527-Src, followed by slower
deactivation of this kinase via dephosphorylation of
pY416Src. Conclusion: These results provide new
insight into the mechanisms governing the dynamics
of Src activity during osteoblast differentiation. A fuller
understanding of these mechanisms will improve our
knowledge of bone metabolism and of the regulation
of Src in other types of cells.
Introduction
Cells respond to internal and external stimuli through
integrated networks of signaling pathways that involve
cascades of sequential phosphorylation or dephosphor-
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ylation mediated by the action of protein kinases and pro-
tein phosphatases. Specifically, tyrosine phosphorylation
is generally accepted as a critical regulator of a variety
of cell biological processes, including cell proliferation,
migration, differentiation, and survival [1].
Of the various protein tyrosine kinases currently
known, Src kinase has an important role in physiological
and pathological processes such as cell survival, differ-
entiation, tumorigenesis and inflammation [2]. Src activ-
ity is also important in bone homeostasis since targeted
disruption of the c-Src gene in mice causes osteopetrosis
by accelerating osteoblast differentiation, whereas
osteoclasts failed to resorb bone because they did not
form ruffled borders [3-5].
The activity of Src-family kinases (including Src, Lyn,
Fyn, Yes, Lck, Blk and Hck) is tightly regulated by their
phosphorylation status [6, 7]. Protein tyrosine kinases are
generally maintained in an inactive conformation by the
phosphorylation of Y527Src, six residues from the c-ter-
minus of c-Src. Under basal conditions in vivo, 90-95%
of Src is phosphorylated at Y527Src [8, 9]. Following de-
phosphorylation of Y527Src, Src undergoes intermolecu-
lar autophosphorylation at Y416, a residue present in the
activation loop; the phosphorylation of this residue pro-
motes kinase activity and association of the kinase with
substrate molecules [10]. Some PTPs (CD45, RPTPα,
PTP1B, Shp1/2, PTPε, PTPκ and LMWPTP) can influ-
ence Src family tyrosine kinase activity by
dephosphorylating Y527Src [11]. In recent years,
LMWPTP has been found to tightly control the activity
of Src and vice versa [12, 13]. Thus, overexpression of
LMWPTP dramatically decreased Src kinase activity in
response to stimulation by PDGF [12]. LMWPTP oc-
curs in the same complex as Src, as shown by co-
immunoprecipitation experiments, and acts as a substrate
for Src. The phosphorylation of Y131 in LMWPTP by Src
increases the enzymatic activity of this phosphatase by
more than 25-fold [14-18]. In contrast to the activation
of Src, well-defined candidates for the deactivation of
this kinase have not yet been identified. Indeed, the mecha-
nisms governing the transient nature of Src kinase sig-
nalling remain poorly understood.
Based on these considerations, in this work we ex-
amined the modulation of Src by LMWPTP during the
differentiation of pre-osteoblast cells. We also investi-
gated the modulation of the activity of these enzymes in
in vitro assays. RNA silencing and phosphatase/kinase
activity assays revealed a dichotomic regulation of Src
tyrosine kinase activity by LMWPTP. This is the first
report to show that LMWPTP is involved in Src activa-
tion during osteoblast differentiation. Additional studies




Antibodies against total-Src (#2108), phosphoY416Src
(#2101), phosphoY527Src (#2105), non-phospho-Y416Src
(#2102), non-phospho-Y527Src (#2107), pan-actin (#4968) and
anti-rabbit, anti-goat and anti-mouse peroxidase-conjugated
antibodies were purchased from Cell Signaling Technology
(Beverly, MA). Sam68 (Src substrate) and antibody against
phospho-tyrosine (α-pY, #sc-508) were purchased from Santa
Cruz Biotechnology (Santa Cruz Biotechnology, CA). Antibody
against LMWPTP was from Abcam. The antibodies were used
at dilutions recommended by the manufacturers. Recombinant
human LMWPTP (rhLMWPTP) was developed by one of the
authors (JMG, unpublished data). All chemicals were of
analytical grade.
Cell culture
MC3T3-E1 pre-osteoblasts (subclone 4) obtained from
the American Type Culture Collection (ATCC) were routinely
grown in modified alpha minimum essential medium (α-MEM;
Sigma Chemical Co., St. Louis, MO) without ascorbic acid,
supplemented with 10% fetal bovine serum (FBS; HyClone,
Logan, UT) and 1% penicillin-streptomycin, in a humidified 5%
CO2 atmosphere at 37°C. The cells were plated at an initial
density of 50,000 cells/cm2 and after 24 h (day 0) differentiation
was induced by adding osteogenic medium (OM) containing
50 µg of ascorbic acid/ml and 10 mM β-glycerophosphate for
28 days. The osteogenic medium was replaced every three days.
Cell fractionation
Cytoskeletal fractions and soluble cellular fractions were
separated by using RIPA lysis buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% Nonidet P-40, 2 mM EGTA, 1 mM sodium
orthovanadate, 1 mM phenylmethanesulfonyl fluoride, 10 µg
of aprotinin/ml, 10 µg of leupeptin/ml). Complete RIPA lysis
buffer (cRIPA) consisted of RIPA plus 0.5% sodium
deoxycholate and 0.1% sodium dodecyl sulfate. Cellular
fractionation was done as described by Cirri et al. [19].
Transfection of MC3T3-E1 cells with LMWPTP
MC3T3-E1 cells grown to 60% confluence (6-well plates)
were transiently transfected with LMW-PTP. The transfections
were done using an Effectene transfection kit (QIAGEN Benelux,
Venlo, Netherlands) according to the manufacturer’s
instructions. Briefly, the cells were transfected with 2.4 µg of
pcDNA3.1/V5-His-TOPO vector with or without an insert
containing the sequence of human LMWPTP after a
cytomegalovirus promoter. Overexpression was always verified
by western blotting.
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Transfection of MC3T3-E1 cells with siLMWPTP
MC3T3-E1 cells grown to 60% confluence (6-well plates)
were transiently transfected with siLMWPTP. The transfections
were done using an Hiperfect transfection kit (QIAGEN Benelux,
Venlo, Netherlands) according to the manufacturer’s
instructions. Briefly, the cells were transfected with LMWPTP
siRNA (final concentration: 5 nM) or MAPK1 siRNA (positive
control) for 72 h, and then scraped into 100 µl of cell lysis
buffer (described in section 2.6), sonicated and spun down.
The lysates were subsequently mixed with loading buffer for
electrophoresis. The efficiency of transfection was assessed
based on the expression of LMWPTP by western blot analysis
(mean reduction in expression: 58.3%).
Immunoblotting and immunoprecipitation
Protein extracts were obtained by using a lysis cocktail
(50 mM Tris-HCl, pH 7.4, 1% Tween 20, 0.25% sodium deoxy-
cholate, 150 mM NaCl, 1 mM EGTA, 1 mM O-vanadate, 1 mM
NaF and protease inhibitors - 1 µg/mL aprotinin, 10 µg/mL
leupeptin, and 1 mM phenylmethanesulphonyl fluoride]) for 2
h on ice. An equal volume of 2 x SDS gel loading buffer (100
mM Tris-HCl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 0.1%
bromophenol blue and 20% glycerol) was added to the sam-
ples and boiled for 5 min. Protein extracts were separated by
SDS-PAGE in 12% polyacrylamide gels and transferred to
polyvinylidene difluoride (PVDF) membranes.
For immunoprecipitation, the cells were lysed in ice-cold
lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-
100, 60 mM n-octylglucoside, 2 mM EDTA, 1 mM
orthovanadate, 100 mM NaF, and proteases inhibitors). After
centrifugation, the lysates were incubated overnight with anti-
pan-Src or phospho-tyrosine antibody at 4°C and then
incubated (rotatory mixing) with Protein A-Sepharose at 4°C
for 2 h. The beads were washed three times with lysis buffer
and twice with phosphate-buffered saline (PBS), after which
the immunoprecipitates were used for enzymatic assays and/
or SDS-PAGE and immunoblotting as described above.
Immunoreactive bands were detected with enhanced
chemiluminescence (ECL) kits.
Phosphatase and kinase activities in vitro
Phosphatase activity: Cells were treated with freshly
prepared pervanadate solution (10 µM) for 30 min and pan-Src
was immunoprecipitated from the cellular lysate (1.5-3.5 mg of
protein/ml). The immunoprecipitate (total Src) was
subsequently incubated with rhLMWPTP at 37°C for 15 min or
30 min and the reaction then stopped by adding pervanadate.
Kinase activity: Kinase activity was assayed by adding 2
µg of Sam68 (protein substrate for Src) and 100 µM ATP to the
samples from the dephosphorylation experiments (described
above) followed by incubation at 37°C for 30 min. The reaction
was terminated by adding loading buffer and the amount of
Sam68 and its degree of phosphorylation were assessed by
immunoblotting.
Cellular redox status
Cells were treated with H2O2 (1 µM), L-NAME (3 µM) and
GSH (5 mM) for 1 h and the cRIPA fraction was collected. Src
phosphorylation (anti-pY416Src) and LMWPTP expression in
the lysates were analyzed by western blotting. The extent of
LMWPTP phosphorylation was assessed by immunopre-
cipitating the enzyme followed by western blotting with α-pY
antibody.
Results
Based on the critical role of Src kinase in bone
homeostasis and its ability to interact with LMWPTP, in
Fig. 1. Phosphorylation of Src and
LMWPTP expression during osteoblast
differentiation. Src phosphorylation (A)
and LMWPTP expression (B) were
evaluated by western blotting. Soluble
lysates were matched for protein content
and analyzed by western blotting. The
western blots were probed with actin
antibody to ensure equal protein loading.
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this work we examined the extent of Src phosphorylation
status and LMWPTP expression during the differentiation
of MC3T3-E1 pre-osteoblasts induced by ascorbic acid
and β-glycerophosphate. We also assessed the
dephosphorylation of Src by LMWPTP in vitro. The use
of ascorbic acid and β-glycerophosphate to induce the
differentiation of pre-osteoblasts (MC3T3-E1 cells) is well
described in the literature and usually occurs after 21-28
days [20]. In this work, successful differentiation was
confirmed by the increase in alkaline phosphatase activity
and osteocalcin expression  up to 28 days (data not
shown).
Covalent modulation of tyrosine phosphorylation
determines Src kinase activity during osteoblast
differentiation
Src activity and its modulation by LMWPTP during
osteoblast differentiation were examined in MC3T3-E1
pre-osteoblasts initially maintained under osteogenic
conditions for 28 days. Subsequently, western blotting with
specific antibodies showed that Src kinase was inactive
during osteoblast differentiation since Y416Src at the
activator site was dephosphorylated (accompanied by a
marked increase in non-phospho-Y416Src) whereas
Y527Src at the inhibitory site was phosphorylated
(accompanied by a marked decrease in non-phospho-
Y527Src) (Figure 1A). These findings indicated that Src
kinase activity changed during osteoblast differentiation
although there was no marked alteration in Src expression
during this process.
In contrast to Src, the expression of LMWPTP
Fig. 2. LMWPTP dephosphorylates Src at
tyrosine residues. Cells were pretreated with
pervanadate for 30 min (to increase pY-Src
levels) and pan-Src (i.e. non-phosphorylated
and phosphorylated-Src) was immunopre-
cipitated and incubated with rhLMWPTP in
vitro for different lengths of time. (A) Equal
amounts of pan-Src were used in the various
experimental conditions, as assessed by
western blotting with a pan-Src antibody (left
panel). MW = molecular weight marker lane. (B)
Western blots of immunoprecipitated
rhLMWPTP-treated Src probed with pY
antibodies. (C) Western blots of immuno-
precipitated rhLMWPTP-treated Src probed
with α-pY antibodies.
varied during osteoblast differentiation, with the highest
expression being detected after 14 and 21 days (Figure
1B). Based on these findings, we speculated that
LMWPTP could influence Src activity during bone
formation.
Fig. 3. LMWPTP dephosphorylates pY416-Src and pY527-Src.
To identify the tyrosine residues of Src that were
dephosphorylated by LMWPTP, total Src was immuno-
precipitated and incubated with rhLMWPTP for various times.
Subsequently, pan-Src, phospho-Src (pY527-Src and pY416-Src),
and non-phospho-Src (Y527-Src and Y416-Src) were analyzed by
western blotting.
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Evidence for pY416Src dephosphorylation via a
tyrosine phosphatase-dependent mechanism
The transient nature of Src activation in response to
various stimuli during bone formation is still poorly
understood. One possible explanation for the transient
Src activity could be that pre-osteoblasts contain PTPs
that dephosphorylate pY416Src, thereby deactivating the
kinase. Evidence for such activity in these cells was
obtained from experiments in which MC3T3-E1 cells were
pretreated with the pan-PTP inhibitor pervanadate
(10 µM) for 30 min. This treatment strongly increased
pY levels in general, and that of pY416Src in particular
(not shown). The ability of pervanadate to block the
dephosphorylation of pY527Src indicated that MC3T3-E1
cells contain strong pY416Src dephosphorylating activity.
This conclusion was supported by the observation that
these cells contained PTP activity towards pY416Src and
suggested that this phosphatase was a plausible negative
regulator of c-Src activity.
pY416Src is a substrate for LMWPTP
Immunoblotting with anti-Src and anti-
phosphotyrosine antibodies was used to investigate the
action of rhLMWPTP on pY416Src following the
co-incubation of pSrc with rhLMWPTP for 15 min and
30 min. Pervanadate-treated MC3T3-E1 cells were used
Fig. 4. Decreased pY416-Src
levels in MC3T3-E1 cells
overexpressing LMWPTP. (A)
Immunocytochemical analysis
of pY416-Src levels. To increase
pY416-Src levels, cells were
incubated with pervanadate for
30 min before transfection with
empty vector or an LMWPTP-
expressing construct, after
which the medium was
replaced by one without
pervanadate. (B) Western blot





as a source of pSrc. Figure 2A shows the levels of total
Src during the reaction with rhLMWPTP. Immunoblotting
with anti-phospho-tyrosine (pY) antibody revealed a
decrease in phosphorylation after incubation with
rhLMWPTP (Figure 2B), indicating that LMWPTP was
able to dephosphorylate immunoprecipitated pSrc and that
this enzyme may be a negative regulator of this kinase.
This finding was supported by a decrease in the levels
of pY in a protein band with a molecular mass similar
to pSrc in immunoprecipitates incubated with
rhLMWPTP (Figure 2C).
LMWPTP dephosphorylates Y416Src and Y527Src
in vitro
Based on the finding that pSrc was a substrate for
LMWPTP, we subsequently examined the preference
of this PTP for pY416Src and pY527Src. By using a
phosphatase assay similar as that described above,
we found that both tyrosine residues of Src were
substrates for LMWPTP (Figure 3). However, LMWPTP
showed greater specificity for pY527Src since there was
a marked decrease in the level of this phosphorylated
residue within 15 min when compared with pY416Src.
This decrease in phosphorylation was accompanied
by a corresponding increase in non-phosphorylated
Y527Src.
LMWPTP Modulates Src Activity Cell Physiol Biochem 2008;22:497-506
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LMWPTP dephosphorylates phospho-Src in cells
To establish whether pSrc can act as a substrate for
LMWPTP in intact cells, we examined the level of
pY416 in MC3T3-E1 cells overexpressing LMWPTP or
empty vector. As shown in Figure 4, the cells generally
had low basal levels of pSrc. To increase the levels of
pY416Src, the cells were preincubated for 30 min
with pervanadate before transfection with empty vector
or an LMWPTP-expressing construct and then incubated
in medium without pervanadate. Comparison of the
upper panel with the middle panel in Figure 4A, or the
western blots in Figure 4B shows that this short
pretreatment was sufficient to substantially increase
pY416Src levels in cells transfected with empty vector,
even after 24 h. Transfection with an LMWPTP construct
(lower panel) resulted in no detection of pY416Src.
These results clearly show that pSrc is an intracellular
substrate for LMWPTP.
LMWPTP is essential for suppressing Src
hyperphosphorylation in cells
The experiments described in the preceding section
indicated that LMWPTP reduced Src phosphorylation,
but did not address the importance of this action in vivo.
To examine this aspect, LMWPTP expression was
Fig. 5. Effect of LMWPTP knock down with siRNA on pY416Src levels. MC3T3-E1 cells grown to 60% confluence were transiently
transfected with siLMWPTP for 72 h. The transfections were done using a Hiperfect transfection kit (Qiagen) according to the
manufacturer’s instructions. The negative control was an irrelevant RNA sequence and the positive control was a sequence
directed against MAPK1 (knock down not shown). The cells were subsequently scraped into cell lysis buffer and transfection
was confirmed by western blotting. β-Actin was used as a loading control. The bar graph shows the relative amounts of
phosphorylated Y416Src and LMWPTP expression corrected for β-actin.
knocked down by using siRNA. A reduction in the
intracellular levels of LMWPTP markedly enhanced
Src phosphorylation (Figure 5). Hence, LMWPTP
not only reduces Src phosphorylation intracellularly, but
also suppresses Src hyperphosphorylation.
The interaction of LMWPTP with Src decreases
Src kinase activity
The apparently antagonistic actions of LMWPTP
at both regulatory sites of Src raised questions as to the
actual effects of LMWPTP on Src catalytic activity.
To investigate this question, Src was dephosphorylated
with LMWPTP in vitro and kinase assays were done
using Sam68 as a substrate for Src to monitor the effect
of LMWPTP on Src activity. The level of tyrosine
phosphorylation of Sam68 was monitored by
immunoblotting with pY20 anti-phosphotyrosine antibody.
As shown in Figure 6, Sam68 was efficiently
phosphorylated by Src when this kinase was not
pre-incubated with LMWPTP. However, after a 30 min
pre-incubation with LMWPTP, the ability of Src to
phosphorylate Sam68 was almost completely
abolished. These experiments unambiguously identified
LMWPTP as a negative regulator of Src enzymatic
activity.
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Fig. 6. LMWPTP modulates Src kinase activity. Src kinase
was immunoprecipitated and incubated with rhLMWPTP for
15 min or 30 min, followed by the addition of 10 µM pervanadate,
Sam68 (Src substrate) and ATP. After incubation for 30 min, the
reaction was terminated and the levels of Sam68 and its
phosphorylation were assessed by western blotting.
Redox status affects the subcellular distribution
of LMWPTP and Src
In view of the importance of the redox status of
cells in modulating the intracellular localization and
activity of PTP in general, we examined the effect of
H2O2,  L-NAME and GSH on the intracellular distribution
and activity of LMWPTP. Changes in the cellular
redox potential resulted in the translocation of
LMWPTP to the RIPA-insoluble cytoskeletal fraction
(Figure 7A). When the reducing potential of cells was
increased by adding L-NAME or GSH, LMWPTP was
translocated to the soluble fraction (cRIPA) - (Figure 7A).
Under the same conditions, there was a decrease in
pYSrc levels that was inversely related to the increase
in LMWPTP levels. Hence, LMWPTP was negatively
correlated with pYSrc, also on a subcellular level.
Cells incubated with GSH showed higher LMWPTP
phosphorylation (Figure 7B). Together, these results
provide further evidence for a role of this
phosphatase in controlling the phosphorylation
of c-Src.
Discussion
Despite the importance of Src kinase in cellular
physiology, including bone homeostasis, many aspects of
the regulation of this enzyme by covalent modulation (via
Y416Src and Y527Src) remain unclear. Since previous re-
ports have demonstrated a role for Src in osteoblast dif-
ferentiation [3-5], in this work we examined the possible
correlation between Src phosphorylation and LMWPTP
expression during this process in pre-osteoblasts stimu-
lated with ascorbic acid and β-glycerophosphate. Firstly,
Src activity was inhibited during differentiation process,
as would be expected, whereas LMWPTP expression
was markedly increased. This finding suggested a possi-
ble relationship between them. Additional support for such
a relationship was obtained from experiments in which
MC3T3-E1 cells were treated with pervanadate. Although
such treatment would be expected to negatively regulate
pY527Src dephosphorylating enzymes and thereby
Fig. 7. LMWPTP activity is modulated by the cellular redox
status. (A) MC3T3 cells were treated with hydrogen peroxide,
L-NAME or GSH for 30 min and cells were fractionated into
RIPA soluble and insoluble fractions. The presence of LMWPTP
and pY416-Src was evaluated in both fractions. (B) Cells treated
with GSH were lysed and LMWPTP was immunoprecipitated,
followed by determination of pY-LMWPTP using α-pY
antibody.
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downregulate pY416Src levels, instead there was increase
in pY416-Src levels. The simplest explanation for this ob-
servation is that these cells contain PTP activity towards
pY416Src, making this phosphatase a plausible negative
regulator for c-Src activity. Among the PTPs, it has been
demonstrated that the LMWPTP is complexed with and
a direct substrate for active Src, and the phosphorylation
of LMWPTP increased its enzymatic activity [14, 19].
Hence, this enzyme could be an attractive candidate to
act as a negative modulator of Src activity. Support for
this hypothesis was obtained from experiments in which
the subcellular distribution of LMWPTP was assessed in
parallel with the phosphorylation of c-Src. The subcellu-
lar localization of many enzymes, such as protein kinase
C, Raf and Src, is influenced by extracellular stimuli, and
detergent phase partitioning is commonly used to isolate
these proteins [19, 21-22]. RIPA buffer is a widely used
lysis buffer that contains non-ionic detergents such as
Triton X-100 or Nonidet P-40. The soluble fraction ob-
tained with RIPA contains cytosolic and plasma mem-
brane structures. As shown here, increasing the redox
potential of the cell resulted in the translocation of
LMWPTP to the RIPA-insoluble cytoskeletal fraction.
This finding agrees with the earlier study of Caselli et al.
[23] who showed that the cellular redox status is a
Fig. 8. Schematic representation of the modulation of Src activity by dephosphorylation. The phosphorylation of Y527 in Src is
crucial for maintaining this enzyme in its inactive conformation since pY527 interacts with the SH2 domain of the kinase and this
intramolecular association stabilises a catalytically inactive form of the enzyme. Following dephosphorylation of Y527Src by
CD45/RPTPα, Src undergoes intermolecular autophosphorylation at Y416, a residue present in the activation loop. The
phosphorylation of Y416 activates kinase activity and leads to the association of Src with substrate molecules, e.g. LMWPTP.
LMWPTP dephosphorylates Y527Src, leading to an increase in kinase activity, in a process defined as rapid mutual activation.
When Y416Src is dephosphorylated by LMWPTP, Src returns to its inactive conformation.
critical determinant of the subcellular localization of
LMWPTP, an effect that is probably related to the phos-
phorylation of Y131 in LMWPTP. The appearance of
LMWPTP in this fraction correlated directly with a
decrease in pSrc levels. Furthermore, artificially increas-
ing the expression of LMWPTP resulted in the
downregulation of pSrc. These findings indicate that pSrc
is a substrate for LMWPTP in vivo.
Our results indicate that LMWPTP apparently has
two distinct actions in transiently modulating Src activity.
On the one hand, modest activation of LMWPTP
dephosphorylates pY527Src. This leads to the
phosphorylation of Y416Src and a subsequent dramatic
increase in PTK activity that in turn results in more
LMWPTP tyrosine phosphorylation and hence more
phosphatase activity (Figure 8). The inherent positive
feedback in this process may explain the rapid increase
in cellular Src activity generally seen after cellular
stimulation. On the other hand, LMWPTP also
dephosphorylates pY416Src, thus temporally limiting Src
activity. This double action makes LMWPTP a prime
candidate in the remarkable dynamics of Src activation
following cellular stimulation.
However, it is possible that the dephosphorylation
of pY527Src is an epiphenomenon with little relevance in
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vivo. This hypothesis is supported by results of this study
showing that LMWPTP acts as a negative regulator of
Src activity. Such a scheme would entail the activation of
Src via the dephosphorylation of pY527Src by other PTPs,
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